SEC Form 4 · accession 0001209191-17-064126
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James R Talevich
Director
Period of report
Dec 5, 2017
Accepted (ET)
Dec 6, 2017 · 11:09 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 5, 2017 | X | 3,189 | $0.456 | A | 64,906 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Subscription Rights (Right to Buy) | $0.456 | Dec 5, 2017 | X | 3,189 | D | Nov 8, 2017 | Nov 29, 2017 | Common Stock | 3,189 | 0 | D |